Liquidia Corp (STU:LT4)

€ 10.92 -0.02 (-0.18%) Market Cap: 925.62 Mil Enterprise Value: 734.65 Mil PE Ratio: 0 PB Ratio: 8.84 GF Score: 66/100

Q3 2024 Liquidia Corp Earnings Call Transcript
Nov 13, 2024

€9.7 (-2.51%)

Earnings
Q2 2024 Liquidia Corp Earnings Call Transcript
Aug 07, 2024

€9.77 (-2.25%)

Earnings
Q1 2024 Liquidia Corp Earnings Call Transcript
May 14, 2024

€10.72 (-3.68%)

Earnings
Q4 2023 Liquidia Corp Earnings Call Transcript
Mar 13, 2024

€13.28 (+4.40%)

Earnings
Liquidia Corp at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 Liquidia Corp Earnings Call Transcript
Nov 07, 2023

€6.06 (-1.30%)

Earnings
Q2 2023 Liquidia Corp Earnings Call Transcript
Aug 10, 2023

€7.12 (+2.15%)

Earnings
Liquidia Corp Corporate Call Transcript
Jun 28, 2023
Liquidia Corp at Bank of America Global Healthcare Conference Transcript
May 09, 2023
Q1 2023 Liquidia Corp Earnings Call Transcript
May 04, 2023

€6.33 (+6.75%)

Earnings
Q4 2022 Liquidia Corp Earnings Call Transcript
Mar 16, 2023

€6.89 (+14.42%)

Earnings
Q3 2022 Liquidia Corp Earnings Call Transcript
Nov 08, 2022

€4.88 (-2.81%)

Earnings
Liquidia Corp Corporate Update on Hatch-Waxman Litigation Call Transcript
Sep 01, 2022
Q2 2022 Liquidia Corp Earnings Call Transcript
Aug 11, 2022

€5.34 (+1.17%)

Earnings
Liquidia Corp Annual Shareholders Meeting Transcript
Jun 16, 2022
Q1 2022 Liquidia Corp Earnings Call Transcript
May 12, 2022

€4.64 (-2.46%)

Earnings
Q4 2021 Liquidia Corp Earnings Call Transcript
Mar 17, 2022

€5.76 (+2.86%)

Earnings
Liquidia Corp Investor Conference Call to Discuss Regulatory Update Transcript
Nov 08, 2021
Q2 2021 Liquidia Corp Earnings Call Transcript
Aug 10, 2021

€2.01 (+2.98%)

Earnings
Liquidia Corp Annual Shareholders Meeting Transcript
Jun 17, 2021
Q1 2021 Liquidia Technologies Inc Earnings Call Transcript
May 13, 2021

€2.22 (-3.64%)

Earnings
Q4 2020 Liquidia Technologies Inc Earnings Call Transcript
Mar 23, 2021

€2.26 (-0.88%)

Earnings
Liquidia Technologies to Discuss Regulatory Update For LIQ861 Transcript
Nov 25, 2020
Liquidia Technologies Inc Extraordinary Shareholders Meeting Transcript
Nov 13, 2020
Q3 2020 Liquidia Technologies Inc Earnings Call Transcript
Nov 09, 2020

€3.38 (+14.19%)

Earnings
Q2 2020 Liquidia Technologies Inc Earnings Call Transcript
Aug 10, 2020

€5.25 (-0.94%)

Earnings
Liquidia Technologies Inc Update Call on Recent Announcements Regarding the Proposed Acquisition of RareGen LLC Transcript
Jun 30, 2020
Liquidia Technologies Inc Annual Shareholders Meeting Transcript
Jun 18, 2020
Q1 2020 Liquidia Technologies Inc Earnings Call Transcript
May 11, 2020

€6.9 (+14.05%)

Earnings
Q4 2019 Liquidia Technologies Inc Earnings Call Transcript
Mar 11, 2020

€2.96 (-11.38%)

Earnings
Q3 2019 Liquidia Technologies Inc Earnings Call Transcript
Nov 13, 2019

€3.12 (-1.89%)

Earnings
Q2 2019 Liquidia Technologies Inc Earnings Call Transcript
Aug 08, 2019

€6.4 (+14.29%)

Earnings
Q1 2019 Liquidia Technologies Inc Earnings Call Transcript
May 02, 2019

€7.36 (-14.02%)

Earnings
Q4 2018 Liquidia Technologies Inc Earnings Call Transcript
Feb 26, 2019

€16.27 (+0.25%)

Earnings

Liquidia Technologies to Discuss Regulatory Update For LIQ861 Transcript

Nov 25, 2020 / 02:00PM GMT

Release Date Price: €2.12 (-17.83%)

Transcript

Operator

Good morning, ladies and gentlemen. My name is Dilem, and I'll be your conference operator today. I would like to welcome everyone to the Liquidia conference call to discuss a regulatory update for LIQ861. (Operator Instructions) I would like to remind everyone that this conference is being recorded.

I would now hand the conference over to Jason Adair, Vice President, Corporate Development and Strategy.

Jason Adair

Liquidia Corporation - VP of Corporate Development & Strategy

Thank you, and good morning, everyone. Welcome to Liquidia's conference call to discuss the regulatory updates for LIQ861.

Before we begin, let me remind you that today's call will include forward-looking statements pursuant to the Private Securities Litigation Reform Act of 1995 relating to, among other things, our expectations concerning next steps in the regulatory review and potential of 861 -- excuse me, approval of 861. Such statements represent management's judgment as of today and may involve significant risks and uncertainties that could cause actual

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.